Phelebothomy in polycystic ovarian syndrome (PCOS)
Phase 2
- Conditions
- polycystic ovarian syndrom.Polycystic ovarian syndrome
- Registration Number
- IRCT2013080514277N1
- Lead Sponsor
- Research Institute for Endocrine Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 120
Inclusion Criteria
PCOS patients
18-45 years old
Hgb more than 12
ferritine more than 20
free of diabetes melitus
free of heart disease
free of hypertension
free of cancer
free of thyroid problem
Exclusion Criteria
pregnancy
?Diabetes
Cardiovascular disease
Hypertension
Thyroid disease
cancer
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Insulin resistance with Homeostatic Model Assessment (HOMA-IR). Timepoint: Before intervention and immediately after intervention (3 month). Method of measurement: Laboratory.;Anti mullerian hormone. Timepoint: Before intervention and immediately after intervention (3 month). Method of measurement: Laboratory assessment.;Prostate-Specific Antigen. Timepoint: Before intervention and immediately after intervention (3 month). Method of measurement: Laboratory.
- Secondary Outcome Measures
Name Time Method Hirsutism Score. Timepoint: Before intervention and immediately after intervention (3 month). Method of measurement: clinical.;Menstural irregularity. Timepoint: Before intervention and immediately after intervention (3 month). Method of measurement: Questionair.